Nos publications

Impact of Granulation Solvent on Release Performance of Dual Matrix Extended-Release Tablets of Highly Water Soluble Drugs Formulated using Compritol® 888 ATO and Methocel® as Release Retarding Agents

  • Poster

AAPS PharmSci360 – Boston (USA)  - oct 2022

Ketkee Deshmukh, Swarnadeep Banerjee, Agnivesh Shrivastava, Sunil Bambarkar

The purpose of this study is to evaluate the impact of different granulation solvents on the performance of dual extended- release matrix tablets, formulated using a combination of Compritol® 888 ATO and Methocel® K100M, with two model APIs:

- highly water-soluble high dose (1000 mg) Metformin Hydrochloride

- freely water-soluble low dose (95 mg) Metoprolol Succinate

Télécharger (.pdf - 2.34 Mo)

Exploring the Potential of Compritol® 888 ATO for Abuse Deterrent Sustained Release Tablets

  • Poster

CRS Annual Meeting – Montreal (Canada)  - jui 2022

Agnivesh Shrivastava ; Renuka Tiwari ; Ketkee Deshmukh and Sunil Bambarkar

Télécharger (.pdf - 853.87 Ko)

Oral Drug Delivery for Modified Release Formulations

  • ebook

Wiley Library - Editors: Edmund S. Kostewicz, Maria Vertzoni, Heather A. E. Benson, Michael S. Roberts - avr 2022

Yvonne Rosiaux, Vincent Jannin and Cécile Morin

In this eBook, Gattefossé describes the strategies for MR formulation development with Lipids (Part II - chapter 11)

Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 2 Studying impact on dissolution profiles of ER tablets of different API’s

  • Poster

CRS Annual Meeting - virtual  - jui 2021

K. Deshmukh1, A. Shrivastava1, S. Banerjee1, R. Tiwari1, S. Bambarkar1, N. Farah2 1Gattefosse India Pvt. Ltd., Mumbai, INDIA, 2Gattefosse SAS, Lyon, FRANCE

Télécharger (.pdf - 832.93 Ko)

Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 1 Studying impact on granule & tablet properties

  • Poster

CRS Annual Meeting - virtual  - jui 2021

K. Deshmukh, A. Shrivastava, S. Banerjee, R. Tiwari, S. Bambarkar, N. Farah Gattefosse India Pvt. Ltd., Mumbai, INDIA, Gattefosse SAS, Lyon, FRANCE

Télécharger (.pdf - 795.45 Ko)

Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 1 Studying impact on granule & tablet properties

  • Poster

CRS Annual Meeting - virtual - jui 2021

K. Deshmukh, A. Shrivastava, S. Banerjee, R. Tiwari, S. Bambarkar, N. Farah Gattefosse India Pvt. Ltd., Mumbai, INDIA, Gattefosse SAS, Lyon, FRANCE

Evolution of the Microstructure of Sustained-release Matrix Tablets during Dissolution and Storage

  • Scientific publication

Indian J Pharm Sci 2018;80(6):1011-1020 - sep 2018

V. Jannin, E. Leccia, Y. Rosiaux, J. Doucet

QbD - How particle size and glyceride composition affect the performance of sustained-release tablets with Compritol 888 ATO

  • Poster

AAPS Annual Meeting & Exposition – San Diego (USA)  - nov 2017

Yvonne Rosiaux, Amandine Forrest, Jean-Michel Girard, Carole Deleglise, Delphine Marchaud

Télécharger (.pdf - 2.46 Mo)

Compritol® 888 ATO: a sustained release lipid matrix for once a day aceclofenac tablets

  • Poster

AAPS Annual Meeting & Exposition – Denver (USA) - nov 2017

C. J. Kapadia, A. R. Shrivastava, G. R. Khanvilkar